Pfizer: Vaccine 91.3% Effective Through 6 Months Plus

Veuer 2021-04-01

Views 48

Pfizer and BioNTech announce their vaccine is 91.3% effective for at least six months. Veuer’s Elizabeth Keatinge has more.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Pfizer-BioNTech vaccine lead: Boosters could be every 12 or 18 months
play
03:55

Pfizer-BioNTech vaccine lead: Boosters could be every 12 or 18 months
COVID-19: Pfizer vaccine effectiveness reportedly declines after 6 months
play
01:16

COVID-19: Pfizer vaccine effectiveness reportedly declines after 6 months
Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months
play
01:08

Pfizer Says COVID-19 Vaccine Protection Lasts at Least 6 Months
Pfizer CEO: New vaccine shot in 6-12 months may be needed | Oneindia News
play
01:33

Pfizer CEO: New vaccine shot in 6-12 months may be needed | Oneindia News
Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years
play
02:39

Pfizer COVID vaccine results show strong immune response in children 6 months to 5 years
Pfizer Coronavirus Vaccine latest News|Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective.
play
00:56

Pfizer Coronavirus Vaccine latest News|Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective.
Covid vaccine big update: Pfizer says vaccine over 90% effective | Oneindia News
play
02:35

Covid vaccine big update: Pfizer says vaccine over 90% effective | Oneindia News
Vaccine expert: Pfizer COVID-19 vaccine, safe and effective para sa edad 5 pababa ayon sa US FDA
play
15:00

Vaccine expert: Pfizer COVID-19 vaccine, safe and effective para sa edad 5 pababa ayon sa US FDA
40 Million Moderna, Pfizer Vaccines Expected in U.S. by the End of the Month
play
01:03

40 Million Moderna, Pfizer Vaccines Expected in U.S. by the End of the Month
Pfizer could have coronavirus vaccine trial results by next month
play
02:11

Pfizer could have coronavirus vaccine trial results by next month
Health DG: We will spend four months to evaluate Pfizer trial data
play
05:26

Health DG: We will spend four months to evaluate Pfizer trial data
Pfizer Says Its Coronavirus Vaccine Effective Against B.1.6.1.7 Variant From India, Seeks Fast Track Approval
play
03:16

Pfizer Says Its Coronavirus Vaccine Effective Against B.1.6.1.7 Variant From India, Seeks Fast Track Approval